{
  "page_summary": "This page provides an example of disease recurrence assessments in the adjuvant and neoadjuvant settings for breast cancer trials, illustrating the use of imaging modalities like CT and MRI at scheduled assessment time points, as well as details of recording procedures in the PR domain. It describes the identification of local, regional, and distant recurrences based on imaging results but does not define or discuss specific clinical trial endpoints.",
  "endpoint_candidates": []
}